Cited by 162Dementia and Cognitive Impairment ResearchRetinal Diseases and TreatmentsAlzheimer's disease research and treatments

Is Age-related Maculopathy Associated with Alzheimer's Disease?: The Rotterdam Study

Klaver, C. C. W., Ott, A., Hofman, A., Assink, J. J. M., Breteler, M. M. B., de Jong, P. T. V. M.·1999·American Journal of Epidemiology

Abstract

The authors examined the relation between age-related maculopathy and Alzheimer's disease in the Rotterdam Study, a prospective population-based study in the Netherlands. From 1990 to mid-1993, subjects aged 75 years or older (n = 1,438) were screened for the presence of age-related maculopathy and Alzheimer's disease, and follow-up examinations were conducted from mid-1 993 to the end of 1994. Subjects with advanced age-related maculopathy at baseline showed an increased risk of incident Alzheimer's disease (relative risk = 2.1, 95% confidence interval: 1.1, 4.3; adjusted for age and gender), but this risk decreased after additional adjustment for smoking and atherosclerosis (relative risk = 1.5, 95% confidence interval: 0.6, 3.5). These findings suggest that the neuronal degeneration occurring in age-related maculopathy and Alzheimer's disease may, to some extent, have a common pathogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/oxfordjournals.aje.a010105

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 12

  1. Pauleikhoff D, Wessing A, Marshall J, et al. Lipids in Bruch's membrane: a pathogenetic factor in age-related pigment epithelium detachment. Chibret Int J Ophthalmol 1992;9:62-9.
  2. Sarks SH. Ageing and degeneration in the macular area: a clin- ico-pathological study. Br J Ophthalmol 1976;60:324-41.
  3. Berg L, McKeel DW, Miller P, et al. Neuropathological indexes of Alzheimer's disease in demented and ND persons aged 80 years and older. Arch Neurol 1988;45:789-93.
  4. Morris JC, Storandt M, McKeel DW Jr, et al. Cerebral amyloid deposition and diffuse plaques in abnormal aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996;46:707-19.
  5. Hofman A, Grobbee DE, de Jong PTVM, et al. Determinants of diseases and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991;7:403-22.
  6. Schroll M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population of 60-year-old men and women. J Chronic Dis 1981 ;34:261-9.
  7. Lee PN. Smoking and Alzheimer's disease: a review of the epidemiologic evidence. Neuroepidemiology 1994;13:131-44.
  8. Ott A, Slooter AJC, Hofman A, et al. Smoking and the risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 1998;351:1840-3.
  9. Holbrook JH. Nicotine addiction. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al, eds. Harrison's principles of internal medicine. 13th ed. New York, NY: McGraw-Hill, 1994:2433-7.
  10. Ellis RJ, Olichney JM, Thai LJ, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience. Part XV. Neurology 1996;46:1592-6.
  11. Strittmacher WJ, Saunders AM, Schmechel DE, et al. Apolipoprotein E: high avidity binding to P-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993 ;90:1977-81.
  12. Souied EH, Benlian P, Amouyel P, et al. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 1998; 125:353-9.

Cited by

Sorted by citations

Authors
Klaver, C. C. W., Ott, A., Hofman, A., Assink, J. J. M., Breteler, M. M. B., & de Jong, P. T. V. M.
Affiliations
Erasmus MC (NL)
Venue
American Journal of Epidemiology
Published
1999-11-01
Volume
150
Issue
9
Pages
963-968
ISSN
  • 0002-9262 (ISSN-L)
  • 1476-6256
OpenAlex
W2156325413
Cited by
162
References
28
Citations by year
2026: 4 · 2025: 1 · 2024: 8 · 2023: 6 · 2022: 10 · 2021: 11 · 2020: 11 · 2019: 7 · 2018: 4 · 2017: 5 · 2016: 6 · 2015: 4 · 2014: 7 · 2013: 13 · 2012: 10
FWCI
1.19
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Epidemiology (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (submittedVersion)
Funders
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Landelijke Stichting voor Blinden en Slechtzienden
  • Stichting voor Ooglijders
  • Stichting Blindenhulp
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
age-related maculopathy, Alzheimer's disease, smoking, atherosclerosis, neurodegeneration, pathogenesis, older adults
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Arteriosclerosis, Female, Humans, Macular Degeneration, Male, Mass Screening, Netherlands, Population Surveillance, Prospective Studies, Risk Factors, Severity of Illness Index, Smoking, Comorbidity, Incidence, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review